Liver Cirrhosis: The Immunocompromised State

Area of Science:

• Immunology
• Hepatology
• Infectious Diseases

Background:

• Cirrhosis-associated immune dysfunction (CAID) presents with systemic inflammation and immunodeficiency.
• CAID severity is progressive, correlating with liver function decline.
• Two inflammation phenotypes exist: low-grade and high-grade systemic inflammation.

Purpose of the Study:

• To investigate the role of systemic inflammation and bacterial translocation in cirrhosis.
• To understand the clinical implications of different inflammation phenotypes in liver cirrhosis.
• To evaluate the impact of bacterial translocation on infection risk and prognosis in cirrhosis patients.

Main Methods:

• The study describes two inflammation phenotypes in cirrhosis.
• It correlates inflammation grades with liver function, bacterial translocation, and organ insufficiency.
• The role of bacterial translocation in persistent inflammation is discussed.

Main Results:

• High-grade systemic inflammation is associated with severe hepatic insufficiency and bacterial translocation.
• Bacterial translocation contributes to persistent systemic inflammation in cirrhosis.
• Increased infection risk and poorer prognosis are linked to high-grade inflammation.

Conclusions:

• Systemic inflammation and immunodeficiency are key features of CAID.
• Bacterial translocation is a significant factor in cirrhosis-associated inflammation and poor outcomes.
• Prophylactic antibiotics can reduce infection events and mortality in cirrhosis patients.